Dr. Reddick discusses Takeda's new partnership with The National Urban League and their effort to address the obstacles that disproportionately hinder access to better health care for historically marginalized populations in the U.S.
Viewpoints
Advertisement
There is a revolutionary force in medicine that has the power to transform outcomes: artificial intelligence (AI).
PCPs must be aware of these genetic syndromes and the risk in patients with a family history of pancreatic cancer.
While 13% of our U.S. population is Black, Black Americans represent 35% of patients with end-stage kidney disease (ESKD).
Human and digital touchpoints create a strong relationship between the individual and their dedicated clinical specialist.
Advertisement
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.